Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Kathy Taromina, DACM, MS, LAc
Dr. Kathy Taromina, co-president of the Seattle Institute of East Asian Medicine, brings over 30 years of experience in acupuncture, Chinese herbal medicine and Asian bodywork therapy. She is also faculty and clinical supervisor at SIEAM.